Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 54767414MMY3004
Abstract
Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma